drugset / Trial / NCT00554177
A Clinical Trial for Post Traumatic Stress Disorder
RandomizedParallel-groupTriple-blindTreatment
Summary
he purpose of this study is to test whether a medication, called mifepristone (commonly known as the ³Morning-After-Pill²), can help to prevent emotional problems after someone has survived a traumatic experience. We are studying this medication for the treatment of Post-traumatic Stress disorder (PTSD.
Timeline
- Start
- 2007-09
- Primary completion
- 2008-09
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mifepristone | Small molecule | 1200 mg | — |